Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Apply
Tocilizumab with Ramantamig
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step